<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Post-transplant <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (PTLD) represents a spectrum of Epstein-Barr virus (EBV)-related clinical diseases, from a benign <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">mononucleosis</z:e>-like illness to a fulminant non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Because a large proportion of children are seronegative at the time of transplantation, recipients are at high risk of contracting primary <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and subsequently developing PTLD </plain></SENT>
<SENT sid="2" pm="."><plain>Surveillance techniques with antibody titers and/or polymerase chain reaction (PCR) may have a role in some high-risk settings </plain></SENT>
<SENT sid="3" pm="."><plain>A 12-year-old boy whose serologic response to EBV was negative during follow-up after liver transplantation (LTx) developed Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, a rare and the most severe variant of <z:e sem="disease" ids="C1333434" disease_type="Neoplastic Process" abbrv="">EBV-related PTLD</z:e>, 32 months after LTx </plain></SENT>
<SENT sid="4" pm="."><plain>He expired possibly due to side effects of treatment </plain></SENT>
<SENT sid="5" pm="."><plain>We recommend that <z:mp ids='MP_0001799'>viral</z:mp> monitoring must be done using PCR during follow-up of pediatric LTx to prevent dramatic outcomes </plain></SENT>
</text></document>